$44.48
00.00%
Pre-Market: Sep 20, 4:39 PM EDT
15 minutes delayed
Comments
Loading...
Avidity Biosciences (RNA) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAvidity Biosciences (NASDAQ:RNA) Stock Quotes, Forecast and News Summary
Avidity Biosciences Stock (NASDAQ: RNA) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 31.00 / 1.56M |
| Day Range | - - - |
| 52 Wk Range | 4.83 - 48.80 |
| Market Cap | $5.26B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 57 |
| Short Interest | 11.3% |
| Days to Cover | 8.18 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Avidity Biosciences Inc
Sector
Health Care
Industry
Biotechnology
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleot...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Avidity Biosciences (RNA) stock?
You can purchase shares of Avidity Biosciences (NASDAQ:RNA) through any online brokerage.
Who are Avidity Biosciences (RNA) competitors?
Other companies in Avidity Biosciences’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).
What is the forecast, or price target, for Avidity Biosciences (RNA) stock?
Avidity Biosciences has a consensus price target of $54.36.
What is the current price for Avidity Biosciences (RNA)?
The stock price for Avidity Biosciences (NASDAQ: RNA) is $44.48 last updated September 20, 2024 at 4:39 PM EDT.
Does Avidity Biosciences (RNA) pay a dividend?
There are no upcoming dividends for Avidity Biosciences.
When is Avidity Biosciences (NASDAQ:RNA) reporting earnings?
Avidity Biosciences’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
Is Avidity Biosciences (RNA) going to split?
There is no upcoming split for Avidity Biosciences.
What sector and industry does Avidity Biosciences (RNA) operate in?
Avidity Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.